Clinical Trial Detail

NCT ID NCT03637764
Title Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Sanofi
Indications

head and neck squamous cell carcinoma

hepatocellular carcinoma

glioblastoma multiforme

ovary epithelial cancer

Therapies

Atezolizumab + Isatuximab

Isatuximab

Age Groups: adult senior

No variant requirements are available.